Literature DB >> 25112870

Thrombin cleavage of osteopontin disrupts a pro-chemotactic sequence for dendritic cells, which is compensated by the release of its pro-chemotactic C-terminal fragment.

Zhifei Shao1, John Morser1, Lawrence L K Leung2.   

Abstract

Thrombin cleavage alters the function of osteopontin (OPN) by exposing an integrin binding site and releasing a chemotactic C-terminal fragment. Here, we examined thrombin cleavage of OPN in the context of dendritic cell (DC) migration to define its functional domains. Full-length OPN (OPN-FL), thrombin-cleaved N-terminal fragment (OPN-R), thrombin- and carboxypeptidase B2-double-cleaved N-terminal fragment (OPN-L), and C-terminal fragment (OPN-CTF) did not have intrinsic chemotactic activity, but all potentiated CCL21-induced DC migration. OPN-FL possessed the highest potency, whereas OPNRAA-FL had substantially less activity, indicating the importance of RGD. We identified a conserved (168)RSKSKKFRR(176) sequence on OPN-FL that spans the thrombin cleavage site, and it demonstrated potent pro-chemotactic effects on CCL21-induced DC migration. OPN-FLR168A had reduced activity, and the double mutant OPNRAA-FLR168A had even lower activity, indicating that these functional domains accounted for most of the pro-chemotactic activity of OPN-FL. OPN-CTF also possessed substantial pro-chemotactic activity, which was fully expressed upon thrombin cleavage and its release from the intact protein, because OPN-CTF was substantially more active than OPNRAA-FLR168A containing the OPN-CTF sequence within the intact protein. OPN-R and OPN-L possessed similar potency, indicating that the newly exposed C-terminal SVVYGLR sequence in OPN-R was not involved in the pro-chemotactic effect. OPN-FL and OPN-CTF did not directly bind to the CD44 standard form or CD44v6. In conclusion, thrombin cleavage of OPN disrupts a pro-chemotactic sequence in intact OPN, and its loss of pro-chemotactic activity is compensated by the release of OPN-CTF, which assumes a new conformation and possesses substantial activity in enhancing chemokine-induced migration of DCs.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Chemokine; Dendritic Cell; Migration; Osteopontin; Thrombin

Mesh:

Substances:

Year:  2014        PMID: 25112870      PMCID: PMC4175350          DOI: 10.1074/jbc.M114.572172

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Phosphorylation-dependent interaction of osteopontin with its receptors regulates macrophage migration and activation.

Authors:  Georg F Weber; Samer Zawaideh; Sherry Hikita; Vikram A Kumar; Harvey Cantor; Samy Ashkar
Journal:  J Leukoc Biol       Date:  2002-10       Impact factor: 4.962

2.  Regulated osteopontin expression by dendritic cells decisively affects their migratory capacity.

Authors:  Guido Schulz; Andreas C Renkl; Anne Seier; L Liaw; Johannes M Weiss
Journal:  J Invest Dermatol       Date:  2008-05-01       Impact factor: 8.551

3.  CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis.

Authors:  Y U Katagiri; J Sleeman; H Fujii; P Herrlich; H Hotta; K Tanaka; S Chikuma; H Yagita; K Okumura; M Murakami; I Saiki; A F Chambers; T Uede
Journal:  Cancer Res       Date:  1999-01-01       Impact factor: 12.701

4.  Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin).

Authors:  R Agnihotri; H C Crawford; H Haro; L M Matrisian; M C Havrda; L Liaw
Journal:  J Biol Chem       Date:  2001-05-25       Impact factor: 5.157

5.  CD44 is not an adhesive receptor for osteopontin.

Authors:  L L Smith; B W Greenfield; A Aruffo; C M Giachelli
Journal:  J Cell Biochem       Date:  1999-04-01       Impact factor: 4.429

6.  A regulated interaction between alpha5beta1 integrin and osteopontin.

Authors:  S T Barry; S B Ludbrook; E Murrison; C M Horgan
Journal:  Biochem Biophys Res Commun       Date:  2000-01-27       Impact factor: 3.575

7.  Thrombin-cleaved fragments of osteopontin are overexpressed in malignant glial tumors and provide a molecular niche with survival advantage.

Authors:  Yasuto Yamaguchi; Zhifei Shao; Shadi Sharif; Xiao-Yan Du; Timothy Myles; Milton Merchant; Griffith Harsh; Michael Glantz; Lawrence Recht; John Morser; Lawrence L K Leung
Journal:  J Biol Chem       Date:  2012-11-30       Impact factor: 5.157

8.  Receptor-ligand interaction between CD44 and osteopontin (Eta-1).

Authors:  G F Weber; S Ashkar; M J Glimcher; H Cantor
Journal:  Science       Date:  1996-01-26       Impact factor: 47.728

Review 9.  Control of osteopontin signaling and function by post-translational phosphorylation and protein folding.

Authors:  Christian C Kazanecki; Dana J Uzwiak; David T Denhardt
Journal:  J Cell Biochem       Date:  2007-11-01       Impact factor: 4.429

10.  Thrombin-cleaved osteopontin regulates hemopoietic stem and progenitor cell functions through interactions with alpha9beta1 and alpha4beta1 integrins.

Authors:  Jochen Grassinger; David N Haylock; Melonie J Storan; Gemma O Haines; Brenda Williams; Genevieve A Whitty; Andrew R Vinson; Cheang Ly Be; Songhui Li; Esben S Sørensen; Patrick P L Tam; David T Denhardt; Dean Sheppard; Peter F Choong; Susan K Nilsson
Journal:  Blood       Date:  2009-05-05       Impact factor: 22.113

View more
  12 in total

1.  Angiotensin 1-7, but not the thrombin-cleaved osteopontin C-terminal fragment, attenuates osteopontin-mediated macrophage-induced endothelial-cell inflammation.

Authors:  Rachel Hamias; Assaf Rudich; George Greenberg; Gabriel Szendro; Talya Wolak
Journal:  Inflamm Res       Date:  2017-11-27       Impact factor: 4.575

Review 2.  Osteopontin in Immune-mediated Diseases.

Authors:  S R Rittling; R Singh
Journal:  J Dent Res       Date:  2015-09-04       Impact factor: 6.116

3.  Tumour-processed osteopontin and lactadherin drive the protumorigenic reprogramming of microglia and glioma progression.

Authors:  A Ellert-Miklaszewska; P Wisniewski; M Kijewska; P Gajdanowicz; D Pszczolkowska; P Przanowski; M Dabrowski; M Maleszewska; B Kaminska
Journal:  Oncogene       Date:  2016-04-04       Impact factor: 9.867

4.  Thrombin cleavage of osteopontin initiates osteopontin's tumor-promoting activity.

Authors:  Sameera Peraramelli; Qi Zhou; Qin Zhou; Bettina Wanko; Lei Zhao; Toshihiko Nishimura; Thomas H Leung; Seiya Mizuno; Mamoru Ito; Timothy Myles; Thomas M Stulnig; John Morser; Lawrence L K Leung
Journal:  J Thromb Haemost       Date:  2022-02-16       Impact factor: 16.036

5.  Stromal cyclin D1 promotes heterotypic immune signaling and breast cancer growth.

Authors:  Timothy G Pestell; Xuanmao Jiao; Mukesh Kumar; Amy R Peck; Marco Prisco; Shengqiong Deng; Zhiping Li; Adam Ertel; Mathew C Casimiro; Xiaoming Ju; Agnese Di Rocco; Gabriele Di Sante; Sanjay Katiyar; Alison Shupp; Michael P Lisanti; Pooja Jain; Kongming Wu; Hallgeir Rui; Douglas C Hooper; Zuoren Yu; Aaron R Goldman; David W Speicher; Lisa Laury-Kleintop; Richard G Pestell
Journal:  Oncotarget       Date:  2017-08-04

6.  Extracellular proteasome-osteopontin circuit regulates cell migration with implications in multiple sclerosis.

Authors:  Chiara Dianzani; Elena Bellavista; Juliane Liepe; Claudia Verderio; Morena Martucci; Aurelia Santoro; Annalisa Chiocchetti; Casimiro Luca Gigliotti; Elena Boggio; Benedetta Ferrara; Loredana Riganti; Christin Keller; Katharina Janek; Agathe Niewienda; Chiara Fenoglio; Melissa Sorosina; Roberto Cantello; Peter M Kloetzel; Michael P H Stumpf; Friedemann Paul; Klemens Ruprecht; Daniela Galimberti; Filippo Martinelli Boneschi; Cristoforo Comi; Umberto Dianzani; Michele Mishto
Journal:  Sci Rep       Date:  2017-03-09       Impact factor: 4.379

7.  The embryonic type of SPP1 transcriptional regulation is re-activated in glioblastoma.

Authors:  Magdalena Kijewska; Marta Kocyk; Michal Kloss; Karolina Stepniak; Zbigniew Korwek; Renata Polakowska; Michal Dabrowski; Anna Gieryng; Bartosz Wojtas; Iwona A Ciechomska; Bozena Kaminska
Journal:  Oncotarget       Date:  2017-03-07

8.  Antibody-mediated targeting of cleavage-specific OPN-T cell interactions.

Authors:  Bettina Wanko; Matteo Tardelli; Alexander Jürets; Angelika Neuhofer; Gerhard Prager; John Morser; Lawrence L Leung; Günther Staffler; Maximilian Zeyda; Thomas M Stulnig
Journal:  PLoS One       Date:  2019-04-05       Impact factor: 3.240

9.  Inhibition of Cellular Adhesion by Immunological Targeting of Osteopontin Neoepitopes Generated through Matrix Metalloproteinase and Thrombin Cleavage.

Authors:  Alexander Jürets; Marie Le Bras; Günther Staffler; Gesine Stein; Lukas Leitner; Angelika Neuhofer; Matteo Tardelli; Edvin Turkof; Maximilian Zeyda; Thomas M Stulnig
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

10.  Comparative Transcriptomic Analysis of Rectal Tissue from Beef Steers Revealed Reduced Host Immunity in Escherichia coli O157:H7 Super-Shedders.

Authors:  Ou Wang; Guanxiang Liang; Tim A McAllister; Graham Plastow; Kim Stanford; Brent Selinger; Le Luo Guan
Journal:  PLoS One       Date:  2016-03-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.